Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Scientists Use Nanosensors for First Time to Measure Cancer Biomarkers in Blood

Blood is filtered and transferred to nanosensors on a chip, which can detect and measure cancer biomarkers. (Photo: Mark Reed)
Blood is filtered and transferred to nanosensors on a chip, which can detect and measure cancer biomarkers. (Photo: Mark Reed)

Abstract:
A team led by Yale University researchers has used nanosensors to measure cancer biomarkers in whole blood for the first time. Their findings, which appear December 13 in the advanced online publication of Nature Nanotechnology, could dramatically simplify the way physicians test for biomarkers of cancer and other diseases.

Scientists Use Nanosensors for First Time to Measure Cancer Biomarkers in Blood

New Haven, CT | Posted on December 14th, 2009

The team—led by Mark Reed, Yale's Harold Hodgkinson Professor of Engineering & Applied Science, and Tarek Fahmy, an associate professor of biomedical and chemical engineering—used nanowire sensors to detect and measure concentrations of two specific biomarkers: one for prostate cancer and the other for breast cancer.

"Nanosensors have been around for the past decade, but they only worked in controlled, laboratory settings," Reed said. "This is the first time we've been able to use them with whole blood, which is a complicated solution containing proteins and ions and other things that affect detection."

To overcome the challenge of whole blood detection, the researchers developed a novel device that acts as a filter, catching the biomarkers—in this case, antigens specific to prostate and breast cancer—on a chip while washing away the rest of the blood. Creating a buildup of the antigens on the chip allows for detection down to extremely small concentrations, on the order of picograms per milliliter, with 10 percent accuracy. This is the equivalent of being able to detect the concentration of a single grain of salt dissolved in a large swimming pool.

Until now, detection methods have only been able to determine whether or not a certain biomarker is present in the blood at sufficiently high concentrations for the detection equipment to give reliable estimates of its presence. "This new method is much more precise in reading out concentrations, and is much less dependent on the individual operator's interpretation," Fahmy said.

In addition to relying on somewhat subjective interpretations, current tests are also labor intensive. They involve taking a blood sample, sending it to a lab, using a centrifuge to separate the different components, isolating the plasma and putting it through an hours-long chemical analysis. The whole process takes several days. In comparison, the new device is able to read out biomarker concentrations in a just a few minutes.

"Doctors could have these small, portable devices in their offices and get nearly instant readings," Fahmy said. "They could also carry them into the field and test patients on site."

The new device could also be used to test for a wide range of biomarkers at the same time, from ovarian cancer to cardiovascular disease, Reed said. "The advantage of this technology is that it takes the same effort to make a million devices as it does to make just one. We've brought the power of modern microelectronics to cancer detection."

Authors of the paper include Eric Stern, Aleksandar Vacic, Nitin Rajan, Jason Criscione, Jason Park, Mark Reed and Tarek Fahmy (all of Yale University); Bojan Ilic (Cornell University); David Mooney (Harvard University).

Citation: 10.1038/NNANO.2009.353

####

About Yale University
Yale University comprises three major academic components: Yale College (the undergraduate program), the Graduate School of Arts and Sciences, and the professional schools. In addition, Yale encompasses a wide array of centers and programs, libraries, museums, and administrative support offices. Approximately 11,250 students attend Yale.

For more information, please click here

Contacts:
Press Contact
Suzanne Taylor Muzzin
203-432-8555

Copyright © Yale University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Dynamic hydrogel used to make 'soft robot' components and LEGO-like building blocks March 22nd, 2019

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Organic semiconductors: One transistor for all purposes March 22nd, 2019

Making solar cells is like buttering bread March 22nd, 2019

Possible Futures

Magnetoresistive sensors for near future innovative development March 22nd, 2019

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Organic semiconductors: One transistor for all purposes March 22nd, 2019

Making solar cells is like buttering bread March 22nd, 2019

Nanomedicine

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature March 21st, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia March 11th, 2019

New optical imaging system could be deployed to find tiny tumors: Near-infrared technology pinpoints fluorescent probes deep within living tissue; may be used to detect cancer earlier March 8th, 2019

Sensors

Magnetoresistive sensors for near future innovative development March 22nd, 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature March 21st, 2019

CEA-Leti Announces Prototype of Next-generation Photo-Acoustic Sensors for Gas Detection: REDFINCH Team Achieves These Capabilities in Mid-infrared Region, Where Many Important Chemical and Biological Species Have Strong Absorption Fingerprints March 21st, 2019

Quantum sensing method measures minuscule magnetic fields: MIT researchers find a new way to make nanoscale measurements of fields in more than one dimension March 15th, 2019

Announcements

Dynamic hydrogel used to make 'soft robot' components and LEGO-like building blocks March 22nd, 2019

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Organic semiconductors: One transistor for all purposes March 22nd, 2019

Making solar cells is like buttering bread March 22nd, 2019

Nanobiotechnology

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature March 21st, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia March 11th, 2019

Computer-designed vaccine elicits potent antibodies against RSV: The nanoparticle platform for this respiratory syncytial virus study will be applied to vaccine research on flu, HIV, and more; Seattle startup Icosavax will advance related clinical trials March 8th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project